Skip to main content

Acute Granulomatous Acanthamoeba Encephalitis in an Immunocompetent Patient



Acanthamoeba sp. are known to cause fatal granulomatous Acanthamoeba encephalitis (GAE) in immunocompromised patients.


The case of a 17 year old immunocompetent patient with acute purulent meningoencephalitis is reported.


After substantial improvement of cerebrospinal fluid under conventional antimicrobial treatment the patient was suffering several relapses. The causative agent was identified as Acanthamoeba lenticulata T5 which entered the CNS through a bone dehiscence of ethmoidal cells. Due to severe vasospasm the patient developed multiple strokes, which led to marked neurologic sequels.


This case report demonstrates successful treatment of usually lethal GAE in an immunocompetent patient with high dose meropenem, linezolid, moxifloxacin and fluconazole followed by a partially adapted antimicrobial combination therapy.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3


  1. Petry F, Torzewski M, Bohl J, et al. Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol. 2006;44(5):1903–4.

    Article  PubMed  Google Scholar 

  2. Martinez AJ, Janitschke K. Acanthamoeba, an opportunistic microorganism: a review. Infection. 1985;13(6):251–6.

    Article  CAS  PubMed  Google Scholar 

  3. Singhal T, Bajpai A, Kalra V, et al. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J. 2001;20(6):623–7.

    Article  CAS  PubMed  Google Scholar 

  4. Mergeryan H. The prevalence of Acanthamoeba in the human environment. Rev Infect Dis. 1991;13(Suppl 5):S390–1.

    PubMed  Google Scholar 

  5. Schuster FL, Visvesvara GS. Opportunistic amoebae: challenges in prophylaxis and treatment. Drug Resist Updat. 2004;7(1):41–51.

    Article  CAS  PubMed  Google Scholar 

  6. Paltiel M, Powell E, Lynch J, Baranowski B, Martins C. Disseminated cutaneous acanthamebiasis: a case report and review of the literature. Cutis. 2004;73(4):241–8.

    PubMed  Google Scholar 

  7. Culbertson CG, Holmes DH, Overton WM. Hartmanella castellani (acanthamoeba sp): preliminary report on experimental chemotherapy. Am J Clin Pathol. 1965;43:361–4.

    CAS  PubMed  Google Scholar 

  8. Das SR, Asiri S, el-Soofi A, Baer HP. Protective and curative effects of rifampicin in Acanthamoeba meningitis of the mouse. J Infect Dis. 1991;163(4):916–7.

    CAS  PubMed  Google Scholar 

  9. Galarza M, Cuccia V, Sosa FP, Monges JA. Pediatric granulomatous cerebral amebiasis: a delayed diagnosis. Pediatr Neurol. 2002;26(2):153–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Peter Lackner.

Additional information

Peter Lackner and Ronny Beer have contributed equally.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lackner, P., Beer, R., Broessner, G. et al. Acute Granulomatous Acanthamoeba Encephalitis in an Immunocompetent Patient. Neurocrit Care 12, 91–94 (2010).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • GAE
  • Granulomatous Acanthamoeba encephalitis
  • Meningoencephalitis